Skip to Main Content

Paper Details

STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy.
3
2023
STAN, STANs, STING, T, T cell, antitumor T cells, cancer, cancers, cyclic dinucleotide, effector T cells, endothelial cell, human, mouse, stimulator of interferon genes, tumor
Author NameAffiliation
Justin M BalkoVanderbilt University Medical Center
Justin M BalkoVanderbilt Ingram Cancer Center, Vanderbilt University Medical Center
Justin M BalkoVanderbilt Institute for Infection, Vanderbilt University Medical Center
Justin M BalkoVanderbilt Center for Immunobiology, Vanderbilt University Medical Center
Wendy Kimryn RathmellVanderbilt University Medical Center
Wendy Kimryn RathmellVanderbilt Ingram Cancer Center, Vanderbilt University Medical Center
Wendy Kimryn RathmellVanderbilt Institute for Infection, Vanderbilt University Medical Center
Wendy Kimryn RathmellVanderbilt Center for Immunobiology, Vanderbilt University Medical Center
  • 1 - 8

Datasets

Release 1.2